Daewoong Pharmaceutical Hosts 'NABOTA Master Class'… Highlighting Safety Amid Growing Demand for High-Dose, Repetitive Treatments

ConferenceNABOTAPositive

AI Analysis

Summary

Daewoong Pharmaceutical hosted a NABOTA Master Class training program for 74 healthcare professionals from 13 countries, emphasizing the safety profile of PrabotulinumtoxinA through anatomy sessions, injection techniques, and hands-on training.

Importance:2/10

Sentiment:

0.60

educational_programtrainingsafety_focusinternational_engagement

Related Companies

$HCTI $GMRE-PA

Read the original article

Published by PR Newswire Clinical Trials on April 24, 2026 4:03 AM

Read Original